Plerixafor Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-03-13 · last update 2026-03-13
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) | Fresenius Kabi USA, LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 03/13/2026 Updated 03/13/2026 Discontinued 03/13/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)